← Mechanisms of action
IL13RA2
SINGLE PROTEINHomo sapiens
Preferred name: Interleukin-13 receptor subunit alpha-2 ChEMBL ↗
Linked proteins
Drugs acting on this target (8)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| yyb-103 | Agonist | experimental | Cell therapy | IL13RA2 agonist |
| air645 | Antisense inhibitor | experimental | Nucleic acid | IL13RA2 antisense inhibitor |
| cintredekin besudotox | Binding agent | experimental | Recombinant protein | IL13RA2 binding agent |
| epc-003 | Immunity, passive | experimental | Cell therapy | IL13RA2 immunity, passive |
| il-13 rα2 ucar-t cell injection | Immunity, passive | experimental | Cell therapy | IL13RA2 immunity, passive |
| bits7201a | Inhibitor | experimental | mAb | IL13RA2 inhibitor |
| il13r alpha peptide | Inhibitor | experimental | Peptide | IL13RA2 inhibitor |
| pf-07275315 | Inhibitor | experimental | Small molecule | IL13RA2 inhibitor |